Epoetin Therapy and Hemoglobin Level Variability in Nondialysis Patients with Chronic Kidney Disease

Background and objectives: Intrapatient variability of hemoglobin (Hb) is a newly proposed determinant of adverse outcome in chronic kidney disease (CKD). We evaluated whether intensity of epoetin therapy affects Hb variability and renal survival in nondialysis CKD. Design, setting, participants, &a...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Minutolo, Roberto, Chiodini, Paolo, Cianciaruso, Bruno, Pota, Andrea, Bellizzi, Vincenzo, Avino, Deborah, Mascia, Sara, Laurino, Simona, Bertino, Valerio, Conte, Giuseppe, De Nicola, Luca
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Nephrology 2009
Soggetti:
Chronic Kidney Disease
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2653671/
https://ncbi.nlm.nih.gov/pubmed/19261821
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.04380808
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi